Local Leaders Celebrate Success of CPMC


PHILADELPHIA, PA – A venerable group of the region's healthcare, governmental, and business leaders will gather at the historic Union League of Philadelphia Wednesday, May 23, to acknowledge the groundbreaking scientific advancements taking place at the Coriell Institute for Medical Research.

As part of the second What's In Your Genes? event, distinguished guests will recognize the accomplishments of the Coriell Personalized Medicine Collaborative, a research study designed to support the promise of genome-informed medicine. The CPMC Study provides individuals with comprehensive reports based on genome analysis and produces genetic and non-genetic risk results for complex disease and reactions to medications.

The evening will commence at 6:00 p.m. with an insightful lecture on the future of personalized medicine from Dr. Michael Christman, President and CEO of Coriell Institute, and one of the event's honorees, Dr. Howard McLeod. Following the discussion, attendees will have an exclusive opportunity to register and enroll in the CPMC Study.

Beginning at 7 p.m., guests will enjoy cocktails and delicious passed hors d'oeuvres, partake in a silent auction, and help honor Dr. McLeod, Ms. Linda M. Rohrer, and Mr. Peter Driscoll, Esq. for their steadfast commitment to the Institute and its progressive agenda.

What's In Your Genes? is an opportunity for local leaders to learn more about the novel and exciting work taking place in South Jersey's backyard, as well as a glimpse into the vast potential of the fast-emerging personalized medicine field.

About Coriell Institute
Coriell Institute for Medical Research is an independent, non-profit biomedical research center based in Camden, New Jersey. Founded in 1953, the Institute is dedicated to unlocking the genetic code of human disease. Coriell is a pioneer in genomics, examining the utility of genetic information in clinical care through the Coriell Personalized Medicine Collaborative (CPMC) research study (cpmc.coriell.org). The Institute is also exploring the promise of induced pluripotent stem cells – stem cells created from skin or blood – and their role in disease research and drug discovery. Additionally, Coriell continues to be recognized as the world's leading biobank, distributing biological samples and offering custom research and biobanking services to scientists around the globe. For more information, visit www.coriell.org or follow @Coriell_Science on Twitter.

Other News